Navigation Links
NIH-Funded Study Demonstrates That Patients Receiving New CPR Devices (ResQPOD® and ResQPump™) and Cooling Have Improved Long-Term Brain Function Following Cardiac Arrest
Date:9/6/2011

survivors treated with either standard CPR or the ResQCPR System had poor neurological function at the time of hospital discharge. 

Dr. Marvin Wayne and colleagues compared long-term neurologic outcomes for those survivors who were treated in one of four ways: 1) standard CPR with no therapeutic hypothermia, 2) standard CPR with therapeutic hypothermia, 3) the ResQCPR System with no therapeutic hypothermia, or 4) the ResQCPR System with therapeutic hypothermia. Therapeutic hypothermia, which cools patients after cardiac arrest, is often used to help improve outcomes after cardiac arrest

ACSI previously demonstrated in laboratory studies that the ResQCPR System triples blood flow to the heart and brain when applied early in the treatment of cardiac arrest. Primary results from the ResQTrial, published earlier this year in The Lancet, demonstrated that use of the ResQPOD and ResQPump combination resulted in a greater than 50 percent increase in the number of patients who survived to hospital discharge with favorable neurological function compared with those treated with standard CPR. The 50% survival benefit was observed up to a year after cardiac arrest.

These new results from the ResQTrial Study will be presented at the American Heart Association in November 2011. ACSI has applied to the FDA to obtain approval of the ResQCPR System in the United States and hopes it will be widely available for patient care in the near future.

The ResQPOD® is an impedance threshold device (ITD) that selectively prevents unnecessary respiratory gases from entering the chest during the chest wall recoil phase of CPR. It is attached within the ventilation circuit between the airway device and the ventilation source. By therapeutically restricting airflow during CPR, the device creates a small but important negative pressure (vacuum) in the chest that has been shown in numerous human and animal clinical trials to increase b
'/>"/>

SOURCE Advanced Circulatory Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NIH-Funded Study Is First to Demonstrate Increased Long-Term Survival With Favorable Neurologic Function Among Patients Receiving CPR Using ACSI ResQPump® and ResQPOD® CPR Devices
2. NIH-Funded Study Is First to Demonstrate Increased Long-Term Survival With Favorable Neurologic Function Among Patients Receiving CPR Using ACSI ResQPump™ and ResQPOD® CPR Devices
3. New NIH-Funded Study Shows Masimo Rainbow SET(R) May Help Clinicians Assess Oxygenation in Children With Sickle Cell Disease
4. Study Uncovers Key Success Factors and Common Failure Points for Launching New Metabolic Products in Todays Competitive Healthcare Market
5. Study Explores Utilization Trends for Prostate Cancer Treatments
6. Pearl Therapeutics Announces Positive Results for Phase 2b Dose-Ranging Study of Formoterol MDI
7. Kuros Completes Patient Recruitment in its European Clinical Study With KUR-023, its Novel Dural Sealant Product Candidate
8. New Study Shows Modified Citrus Pectin Activates Powerful Immune Responses
9. Ultragenyx Initiates Phase 1 Clinical Study of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Muscle Wasting Disease
10. Comparative Study Confirms Enox Biopharmas Antimicrobial Superiority to Commercially Available Silver Coated Catheters
11. Allergy Technologies LLC Provides Over $100,000 in a Research Grant to The Ohio State University for the Study of Bed Bugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... SANTA CLARA, Calif. , Oct. 22, 2014 /PRNewswire/ ... today announced the introduction of the cQUB™-1 (cQuest Ultrasound ... cQUB white-label ultrasound systems designed and manufactured by Cephasonics ... brand name and model number. Cephasonics will be showcasing ... 2014 being held this week in Chongqing, ...
(Date:10/22/2014)... 2014  Charlene Vernak, RPh, of Vernak Farms Pharmacy ... was awarded the George Roentsch Scholarship by the Professional ... in Houston during PCCA,s International ... annually to an independent pharmacist and PCCA member who ... Roentsch , a well-known pharmacist in the compounding community. ...
(Date:10/22/2014)... 2014 A new report by ... type, Form, End user, Application and Geography) - Size, ... Report, Opportunities, Segmentation and Forecast, 2013 - 2020", considers ... on key trends tracked, it is anticipated that the ... by 2020, registering a CAGR of 6.2% from 2014 ...
Breaking Medicine Technology:Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 3PCCA Awards Charlene Vernak, RPh, the George Roentsch Scholarship 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 4
... Patients with ADD/ADHD -- NESS ZIONA, Israel, November 9, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we need to grab ...
... 9, 2010 Alere Inc. (NYSE: ALR ), ... their health at home through the merger of rapid diagnostics ... Lazard Capital Markets 7th Annual Healthcare Conference being held November ...  Jon Russell, Vice President, Finance, will attend.  Mr. Russell,s presentation ...
Cached Medicine Technology:NeuroDerm Initiates Phase 2 Study of ND0801 in Patients with ADD/ADHD 2NeuroDerm Initiates Phase 2 Study of ND0801 in Patients with ADD/ADHD 3NeuroDerm Initiates Phase 2 Study of ND0801 in Patients with ADD/ADHD 4NeuroDerm Initiates Phase 2 Study of ND0801 in Patients with ADD/ADHD 5NeuroDerm Initiates Phase 2 Study of ND0801 in Patients with ADD/ADHD 6NeuroDerm Initiates Phase 2 Study of ND0801 in Patients with ADD/ADHD 7NeuroDerm Initiates Phase 2 Study of ND0801 in Patients with ADD/ADHD 8
(Date:10/22/2014)... Lintelus, Inc., an event software provider, announced ... will be speaking on the subject of “Event Technology ... 28, at the Holiday Inn in New York City. ... as a Tech Demo at 12:45pm, to educate event ... engaging event experience. , The Annual Meetings Technology Expo ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. ... fertilization (IVF) are only about half as likely as white ... new research indicates, and the racial disparity persists even when ... percent of white patients became pregnant after IVF, compared to ... 4,000 IVF cycles over two years to tease out the ...
(Date:10/22/2014)... 21, 2014 (HealthDay News) -- Measures taken by Firestone ... Ebola-ravaged Liberia may have limited the spread of the ... The Firestone Natural Rubber Co. provides health services ... of nearby densely populated communities. Between Aug. 1 ... Ebola cases among those 80,000 people. That incidence rate ...
(Date:10/20/2014)... With a mere 19 days to November ... brief fundraising stop at the  Law Offices of ... a debate last night with his opponent Gov. Rick ... first seven minutes because Crist had an electric fan ... in one word: "weird." , Before touching on his ...
(Date:10/20/2014)... Women’s health specialist, Dr. Amber Murphy, MD, Ob/Gyn ... Inc., A Division of MaternOhio Clinical Associates, Inc., who ... patients annually. Dr. Murphy will provide a full range ... women’s life. She is accepting new patients at two ... , Dr. Murphy offers a wide variety of services ...
Breaking Medicine News(10 mins):Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 3Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 2Health News:OhioHealth Welcomes New Women’s Health Specialist to MaternOhio Specialists in Obstetrics & Gynecology of Columbus, Inc. 3
... , SCHAFFHAUSEN, Switzerland, Nov. 30 Tyco ... its 2010 annual general meeting of shareholders will be held ... time at the Park Hyatt Zurich Hotel, Beethoven-Strasse 21, 8002 ... record date) will be entitled to vote at the annual ...
... tiny period of time between the registration of a visual stimulus ... between the time we see an apple and the time we ... but by how long? And how does this affect our reactions ... the time delay lasts only 100 milliseconds, others say 500 milliseconds. ...
... in animals , MONDAY, Nov. 30 (HealthDay News) -- Two ... human-derived umbilical cord blood could help treat some lung and ... cells can differentiate into a long list of different kinds ... the Samsung Medical Center in Seoul, Korea, co-author of one ...
... N.J., Nov. 30 Kemin Foods, L.C. ("Kemin") and ... ("OmniActive") have reached an amicable settlement of their dispute. ... ("the ,714 patent") titled "Process for Isolation, Purification and ... Thereof" and the reissues of that patent are valid ...
... , NASHVILLE, Tenn., Nov. 30 During this time ... a loved one with Alzheimer,s disease or other form of dementia, ... Brookdale Senior Living , one of the leading providers of ... care , offers these suggestions. , A listening device with ...
... Europa Uomo, the European,advocacy movement for the fight ... as part of their long-term commitment to increase ... urological diseases. Professor Per-Anders Abrahamsson, Secretary-General of the ... Uomo will gain access to the latest information ...
Cached Medicine News:Health News:Now you see it, now you know you see it 2Health News:Gift Ideas for Loved Ones with Alzheimer's/Dementia 2
Curved osteotome for bone removing....
... new Spectral system is a combination Spectral ... Ophthalmoscope (SLO) system that provides suberb, high-quality ... structure. With the advancements of spectral technology, ... up to 27,000 A-Scans per second and ...
... The SC is an ... cardiology loads, with the ability ... studies, spot views, Myocardial perfusion ... offering a low cost and ...
... intended for: embolization of those intracranial aneurysms ... or the patient's general medical condition - ... be a) very high risk for management ... GDC is also intended for embolization of ...
Medicine Products: